GlassScriptPhysician profile
Yonghyun Lee
NPI 1104278027
$538.34
in general payments reported to CMS, 2019-2025
9 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2023: $21.32 · 2024: $24.73 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $121.85 | 2025 | Wegovy |
| Inspire Medical Systems, INC. | $103.13 | 2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $92.22 | 2019 | |
| Janssen Pharmaceuticals, INC | $79.61 | 2019 | |
| Pfizer INC. | $60.31 | 2019 | |
| Abbott Laboratories | $24.73 | 2024 | Freestyle Libre 3 |
| Curonix LLC | $21.32 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Glaxosmithkline, LLC. | $17.82 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yonghyun Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.